Showing results (731-740 of 778) with videos related to
Sort By:
Pageof 78
The Review of Scientific Instruments|November 8, 2018
Implementation of a 1-2 keV point-projection x-ray spectrometer on the National Ignition FacilityJ A King, Y P Opachich, E J Huffman, et al.Nature Cell Biology|July 13, 2010
Telomere-independent Rap1 is an IKK adaptor and regulates NF-kappaB-dependent gene expressionHsiangling Teo, Sourav Ghosh, Hendrik Luesch, et al.The Review of Scientific Instruments|November 1, 2022
Sub-keV design for the National Ignition Facility's soft x-ray Opacity Spectrometer (OpSpec) and expansion plans for time-resolved measurementsM S Wallace, J M Heinmiller, E C Dutra, et al.Circulation. Genomic and Precision Medicine|February 7, 2024
Targeted Proteomics Reveals Functional Targets for Early Diabetes Susceptibility in Young AdultsRavi V Shah, Jiawei Zhong, Lucas Massier, et al.Journal of Inherited Metabolic Disease|May 20, 2005
Inhibition of energy metabolism by 2-methylacetoacetate and 2-methyl-3-hydroxybutyrate in cerebral cortex of developing ratsR B Rosa, P F Schuck, D R de Assis, et al.Epilepsia|January 19, 2023
Associations between testing and treatment pathways in lesional temporal or extratemporal epilepsy: A census survey of NAEC center directorsChristopher W Beatty, Stephanie M Ahrens, Kristen H Arredondo, et al.Journal of Child Neurology|October 25, 2024
Associations Between Testing and Treatment Pathways in a Case of Pediatric Nonlesional Epilepsy: A Census Survey of NAEC Center DirectorsChristopher W Beatty, Stephanie M Ahrens, Kristen H Arredondo, et al.Circulation Research|April 25, 2024
Proteomics, Human Environmental Exposure, and Cardiometabolic RiskAndrew S Perry, Kai Zhang, Venkatesh L Murthy, et al.The Review of Scientific Instruments|October 3, 2014
Development of a Big Area BackLighter for high energy density experimentsK A Flippo, J L Kline, F W Doss, et al.Molecular Oncology|June 22, 2018
Integrating biomarkers across omic platforms: an approach to improve stratification of patients with indolent and aggressive prostate cancerKeefe Murphy, Brendan T Murphy, Susie Boyce, et al.Pageof 78